223 related articles for article (PubMed ID: 31257172)
21. Leaflet modification or chimney stenting in patients at risk for coronary artery obstruction in valve-in-valve procedure for a failed surgical bioprosthetic aortic valve.
Montarello NJ; Quagliana A; Søndergaard L; De Backer O
Catheter Cardiovasc Interv; 2023 Feb; 101(3):655-659. PubMed ID: 36651342
[TBL] [Abstract][Full Text] [Related]
22. Safeguards and pitfalls for Bioprosthetic or Native Aortic Scallop Intentional Laceration to Prevent Iatrogenic Coronary Artery Obstruction during transcatheter aortic valve replacement-the BASILICA technique.
Bruce CG; Greenbaum AB; Babaliaros VC; Rogers T; Lederman RJ; Khan JM
Ann Cardiothorac Surg; 2021 Sep; 10(5):700-707. PubMed ID: 34733702
[TBL] [Abstract][Full Text] [Related]
23. Bioprosthetic Aortic Scallop Intentional Laceration to prevent Iatrogenic Coronary Artery obstruction (BASILICA) in valve-in-valve Transcatheter Aortic Valve Implantation (ViV-TAVI): First experience in Poland.
Jędrzejczyk S; Rymuza B; Ścisło P; Grodecki K; Pędzich-Placha E; Grabowski M; Kochman J; Huczek Z
Kardiol Pol; 2022; 80(12):1266-1267. PubMed ID: 36161589
[No Abstract] [Full Text] [Related]
24. CoreValve bioprosthesis dysfunction treated with a Sapien 3 valve-in-valve transcatheter aortic valve replacement and BASILICA technique.
Sharma RK; Tuttle MK; Poulin MF; Laham RJ
Catheter Cardiovasc Interv; 2021 Aug; 98(2):403-406. PubMed ID: 33595150
[TBL] [Abstract][Full Text] [Related]
25. Intentional transcatheter laceration of the coronary cusp to prevent left main stem obstruction during transcatheter aortic valve implantation: first European experience with the BASILICA technique in a native aortic valve.
Kasel AM; Khan JM; Greenbaum AB; Michel JM
Eur Heart J; 2019 May; 40(17):1384-1385. PubMed ID: 30445638
[No Abstract] [Full Text] [Related]
26. Bioprosthetic Valve Leaflet Displacement During Valve-in-Valve Intervention: An Ex Vivo Bench Study.
Hensey M; Sellers S; Sathananthan J; Lai A; Landes U; Alkhodair A; McManus B; Cheung A; Wood D; Blanke P; Leipsic J; Ye J; Webb J
JACC Cardiovasc Interv; 2020 Mar; 13(6):667-678. PubMed ID: 32113932
[TBL] [Abstract][Full Text] [Related]
27. Bioprosthetic Aortic Scallop Intentional Laceration to prevent Iatrogenic Coronary Artery obstruction (BASILICA): the first experience in Poland.
Protasiewicz M; Kosowski M; Onisk G; Reczuch K; Przybylski R; Kubler P
Kardiol Pol; 2021; 79(10):1149-1150. PubMed ID: 34292560
[No Abstract] [Full Text] [Related]
28. Systematic use of intentional leaflet laceration to prevent TAVI-induced coronary obstruction: feasibility and early clinical outcomes of the BASILICA technique.
Kitamura M; Majunke N; Holzhey D; Desch S; Bani Hani A; Krieghoff C; Gutberlet M; Protsyk V; Ender J; Borger MA; Dvir D; Thiele H; Abdel-Wahab M
EuroIntervention; 2020 Oct; 16(8):682-690. PubMed ID: 32597392
[TBL] [Abstract][Full Text] [Related]
29. Feasibility of Coronary Access and Aortic Valve Reintervention in Low-Risk TAVR Patients.
Rogers T; Greenspun BC; Weissman G; Torguson R; Craig P; Shults C; Gordon P; Ehsan A; Wilson SR; Goncalves J; Levitt R; Hahn C; Parikh P; Bilfinger T; Butzel D; Buchanan S; Hanna N; Garrett R; Buchbinder M; Asch F; Garcia-Garcia HM; Okubagzi P; Ben-Dor I; Satler LF; Waksman R
JACC Cardiovasc Interv; 2020 Mar; 13(6):726-735. PubMed ID: 32192693
[TBL] [Abstract][Full Text] [Related]
30. Effect of leaflet laceration on transcatheter aortic valve replacement fluid mechanics and comparison with surgical aortic valve replacement.
Sadri V; Kohli K; Ncho B; Inci EK; Perdoncin E; Lisko JC; Lederman R; Greenbaum AB; Babaliaros V; Yoganathan AP
J Thorac Cardiovasc Surg; 2023 Oct; 166(4):e130-e141. PubMed ID: 37086238
[TBL] [Abstract][Full Text] [Related]
31. The effect of clinically recommended Evolut sizes on anchorage forces after BASILICA.
Yaakobovich H; Plitman Mayo R; Zaretsky U; Finkelstein A; Weiss D; Marom G
J Biomech; 2021 Mar; 118():110303. PubMed ID: 33601185
[TBL] [Abstract][Full Text] [Related]
32. Leaflet Prolapse After BASILICA and Transcatheter Aortic Valve Replacement.
Kitamura M; Pighi M; Ribichini F; Abdel-Wahab M
JACC Cardiovasc Interv; 2020 Aug; 13(15):e143-e145. PubMed ID: 32473886
[No Abstract] [Full Text] [Related]
33. Does Undersizing of Transcatheter Aortic Valve Bioprostheses during Valve-in-Valve Implantation Avoid Coronary Obstruction? An In Vitro Study.
Stock S; Scharfschwerdt M; Meyer-Saraei R; Richardt D; Charitos EI; Sievers HH; Hanke T
Thorac Cardiovasc Surg; 2017 Apr; 65(3):218-224. PubMed ID: 27304222
[No Abstract] [Full Text] [Related]
34. Commissural Versus Coronary Optimized Alignment During Transcatheter Aortic Valve Replacement.
Redondo A; Baladrón Zorita C; Tchétché D; Santos-Martinez S; Delgado-Arana JR; Barrero A; Gutiérrez H; Serrador Frutos A; Ybarra Falcón C; Gómez MG; Carrasco Moraleja M; Sevilla T; Sanchez Lite I; Sanz E; San Román JA; Amat-Santos IJ
JACC Cardiovasc Interv; 2022 Jan; 15(2):135-146. PubMed ID: 35057983
[TBL] [Abstract][Full Text] [Related]
35. The first transapical transcatheter aortic valve-in-valve implantation using the J-valve system into a failed biophysio aortic prosthesis in a patient with high risk of coronary obstruction.
Ye J; Lee AJ; Blanke P; Webb J
Catheter Cardiovasc Interv; 2018 Nov; 92(6):1209-1214. PubMed ID: 29602249
[TBL] [Abstract][Full Text] [Related]
36. Bioprosthetic aortic valve durability in the era of transcatheter aortic valve implantation.
Salaun E; Clavel MA; Rodés-Cabau J; Pibarot P
Heart; 2018 Aug; 104(16):1323-1332. PubMed ID: 29735584
[TBL] [Abstract][Full Text] [Related]
37. Transcatheter Aortic Valve-in-Valve Replacement for Degenerated Stentless Bioprosthetic Aortic Valves: Results of a Multicenter Retrospective Analysis.
Miller M; Snyder M; Horne BD; Harkness JR; Doty JR; Miner EC; Jones KW; O'Neal KR; Reid BB; Caine WT; Clayson SE; Lindley E; Gardner B; Connors RC; Bowles BJ; Whisenant BK
JACC Cardiovasc Interv; 2019 Jul; 12(13):1217-1226. PubMed ID: 31272667
[TBL] [Abstract][Full Text] [Related]
38. Toward Transcatheter Leaflet Removal With the CATHEDRAL Procedure: CATHeter Electrosurgical Debulking and RemovAL.
Babaliaros VC; Gleason PT; Xie JX; Khan JM; Bruce CG; Byku I; Grubb K; Paone G; Rogers T; Lederman RJ; Greenbaum AB
JACC Cardiovasc Interv; 2022 Aug; 15(16):1678-1680. PubMed ID: 35981843
[No Abstract] [Full Text] [Related]
39. Valve-in-valve TAVI and risk of coronary obstruction: Validation of the VIVID classification.
Tomii D; Okuno T; Lanz J; Stortecky S; Reineke D; Windecker S; Pilgrim T
J Cardiovasc Comput Tomogr; 2023; 17(2):105-111. PubMed ID: 36754691
[TBL] [Abstract][Full Text] [Related]
40. Risk and Mitigation of Coronary Obstruction in Transcatheter Aortic Valve Replacement.
Medranda GA; Rogers T
Interv Cardiol Clin; 2021 Oct; 10(4):481-490. PubMed ID: 34593111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
